SFX by Ex Libris Inc.

Title:	Agonist-bound structure of the human P2Y12 receptor
Source:	Nature [0028-0836] Zhang, J yr:2014

Basic

Full text

Full text available via Nature

Year:

Volume:

Issue:

Start Page:

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Gao, Raymond C. "Structure of an Agonist-Bound Human A2A Adenosine Receptor." Science 332.6027 (2011): 322-327.
description	2.	Becker, Harold C. "Antiplatelet therapy in prevention of cardio- and venous thromboembolic events." Journal of thrombosis and thrombolysis 37.3 (2013): 362-371.
description	3.	Kavita Kakarala, K. "Sequence -Structure based Phylogeny of GPCR Class A Rhodopsin receptors." Molecular phylogenetics and evolution 74.1 (2014): 66-96.
description	4.	Andrews, Stephen P. "Structure-Based and Fragment-Based GPCR Drug Discovery." ChemMedChem 9.2 (2013): 256-275.
description	5.	Jacobson, Z. "Architecture of P2Y nucleotide receptors: Structural comparison based on sequence analysis, mutagenesis, and homology modeling." Journal of medicinal chemistry 47.22 (2004): 5393-5404.
description	6.	Bara-Jimenez, W. "Adenosine A(2A) receptor antagonist treatment of Parkinson's disease." Neurology 61.3 (2003): 293-6.
description	7.	Veli-Pekka, J. "The 2.6 Angstrom Crystal Structure of a Human A2A Adenosine Receptor Bound to an Antagonist." Science 322.5905 (2008): 1211-1217.
description	8.	Lebon, G. "Agonist-bound adenosine A(2A) receptor structures reveal common features of GPCR activation." Nature 474.7352 (2011): 521-525.
description	9.	Chen L, L. "X-ray structures of AMPA receptor-cone snail toxin complexes illuminate activation mechanism." Science 345.6200 (2014): 1021-1026.
description	10.	Katritch, V. "Structure-Based Discovery of Novel Chemotypes for Adenosine A(2A) Receptor Antagonists." Journal of medicinal chemistry 53.4 (2010): 1799-809.
description	11.	Koch, U. "Cheminformatics at the interface of medicinal chemistry and proteomics." Biochimica et biophysica acta. Proteins and proteomics 1844.1 PART A (2014): 156-161.
description	12.	Bass, C. "Conserved residues in RF-NH₂ receptor models identify predicted contact sites in ligand-receptor binding." Peptides 53 (2014): 278-85.
description	13.	Gloriam, D. "Nine new human Rhodopsin family G-protein coupled receptors: identification, sequence characterisation and evolutionary relationship." Biochimica et biophysica acta. G, General subjects 1722.3 (2005): 235-246.
description	14.	"Mahalingam, Ramaswami." New directions for child and adolescent development 141 (2013): 25-.
description	15.	Burns, J. "An audit of management practices in patients with suspected temporary monocular blindness." British journal of ophthalmology 98.6 (2013): 730-733.
description	16.	Hoefer, T. "12 Relationship between proportions of P2Y12 inhibited platelets and aggregation in vitro." Heart 97.20 (2011): 6-6.
description	17.	Eidam, O. "Fragment-guided design of subnanomolar β-lactamase inhibitors active in vivo." Proceedings of the National Academy of Sciences of the United States of America 109.43 (2012): 17448-17453.
description	18.	Pellegrini, Frederick D. "Prevention of Venous Thromboembolism After Hip or Knee Arthroplasty: Findings From a 2008 Survey of US Orthopedic Surgeons." The Journal of arthroplasty 27.5 (2011): 659-6600000.
description	19.	"Transesophageal echocardiographic correlates of thromboembolism in high-risk patients with nonvalvular atrial fibrillation. The Stroke Prevention in Atrial Fibrillation Investigators Committee on Echocardiography." Annals of Internal Medicine 128.8 (1998): 639-647.
description	20.	Tiberi, M. "Role of the extracellular amino terminus and first membrane-spanning helix of dopamine d1 and d5 receptors in shaping ligand selectivity and efficacy." Cellular signalling 22.1 (2009): 106-116.